A study of: Selective PP2A enhancement through biased heterotrimer stabilization. Leonard D, Huang W, et al.

Published: 26 February 2020| Version 1 | DOI: 10.17632/5sdnbktpg6.1
Contributor:
Daniel Leonard

Description

Here we define the structural and biological basis by which a class of small molecules (lead compound denoted DT-061), selectively binds and stabilizes a single B-subunit containing Protein Phosphatase 2A (PP2A) heterotrimer to drive the targeted dephosphorylation of select PP2A substrates that include c-MYC. This work provides structural and molecular insights into PP2A holoenzyme regulation, identifies a new therapeutic strategy for protein complex targeting and activation, and presents a basis for phosphatase activating therapeutics.

Files

Institutions

Case Western Reserve University, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Categories

Molecular Biology, Structural Biology, Cancer, Protein Phosphatase, Therapeutics

Licence